Study related to effect of a medicine by the name of granisetron

Study of intravenous granisetron on hemodynamic changes and motor and sensory blockade in spinal anaesthesia with hyperbaric bupivacaine in patient undergoing infraumblical surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019193

Enrollment

Registered

2019-05-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Intravenous administration of Granisetron: Dose - 1gm Route - Intravenous Frequency - single dose five minutes spinal anaesthesia Duration of surgery 2 hours Control Intervention1: Norm

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status 1 and 2 Patients undergoing infraumblical surgery under spinal anaesthesia

Exclusion criteria

Exclusion criteria: Patient refusal Patient with known spinal deformity Patients with ASA physical status 3 and 4

Design outcomes

Primary

Measure	Time frame
To study the effect of granisetron on hemodynamic changes and motor and sensory blockade in spinal anaesthesia with hyperbaric bupivacaine in patients undergoing infraumblical surgeryTimepoint: From administration of drug to upto 2 hours in post operative period.	—

Secondary

Measure	Time frame
To see any adverse effect of intravenous granisetron before spinal anaesthesiaTimepoint: From administration of drug to upto 2 hours in post operative period.	—

Countries

India

Contacts

Public ContactDr Prof K H Raghwendra

Indira Gandhi Institute of Medical Sciences

dr.khraghwendra@ymail.com9473191811

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026